Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Angewandte Chemie (International Ed. in English)|February 24, 2024
Site- and Stereoselective Glycomodification of Biomolecules through Carbohydrate-Promoted Pictet-Spengler ReactionBo Liu, Xiangman Zou, Yue Zhang, et al.
Nano-Micro Letters|July 7, 2026
Flexible Dual-Modal Sensing Transistor Enabled by Deep Learning Decoupling for Independent Light and Temperature ReconstructionShilin Lu, Ji Hoon Han, Dong Keun Lee, et al.
Journal of Clinical Pharmacology|October 10, 2019
A Population Pharmacokinetic Model of Oral Docetaxel Coadministered With Ritonavir to Support Early Clinical DevelopmentHuixin Yu, Julie M Janssen, Emilia Sawicki, et al.
Pharmaceutical Research|August 1, 2018
Characterization of Intestinal and Hepatic CYP3A-Mediated Metabolism of Midazolam in Children Using a Physiological Population Pharmacokinetic Modelling ApproachJanneke M Brussee, Huixin Yu, Elke H J Krekels, et al.
Investigational New Drugs|April 20, 2020
Quantification of the pharmacokinetic-toxicodynamic relationship of oral docetaxel co-administered with ritonavirHuixin Yu, Julie M Janssen, Vincent A de Weger, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 11, 2018
First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm NeonatesJanneke M Brussee, Huixin Yu, Elke H J Krekels, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 10, 2026
Loss of CSE couples with BRAF V600E to fuel thyroid cancer metastatic progression through zinc-dependent activation of the EMT machineryShichen Xu, Huixin Yu, Hongxun Wu, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 6, 2018
Drugs Being Eliminated via the Same Pathway Will Not Always Require Similar Pediatric Dose AdjustmentsElisa A M Calvier, Elke H J Krekels, Huixin Yu, et al.
CNS Drugs|March 2, 2022
Population Pharmacokinetic-B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple SclerosisHuixin Yu, Gordon Graham, Olivier J David, et al.
British Journal of Clinical Pharmacology|November 14, 2014
Integrated semi-physiological pharmacokinetic model for both sunitinib and its active metabolite SU12662Huixin Yu, Neeltje Steeghs, Jacqueline S L Kloth, et al.
Pageof 10